Home
Resources
Publications
Stearyl Polyethylenimine Complexed With Plasmids as the Core of Human Serum Albumin Nanoparticles Noncovalently Bound to CRISPR/Cas9 Plasmids or siRNA for Disrupting or Silencing PD-L1 Expression for Immunotherapy

Stearyl Polyethylenimine Complexed With Plasmids as the Core of Human Serum Albumin Nanoparticles Noncovalently Bound to CRISPR/Cas9 Plasmids or siRNA for Disrupting or Silencing PD-L1 Expression for Immunotherapy

Wei-Jie Cheng, Ling-Chun Chen, Hsiu-O Ho, Hong-Liang Lin, Ming-Thau Sheu

Int J Nanomedicine. 2018 Nov 2;13:7079-7094.

PMID: 30464460

Abstract:

Purpose:
In this study, a double emulsion method for complexing plasmids with stearyl poly-ethylenimine (stPEI) as the core to form human serum albumin (HSA) (plasmid/stPEI/HSA) nanoparticles (NPs) was developed for gene delivery by non-covalently binding onto plasmid/stPEI/HSA nanoparticles with CRISPR/Cas9 or siRNA, which disrupts or silences the expression of programmed cell death ligand-1 (PD-L1) for immunotherapy.
Materials and methods:
Chemically synthesized stearyl-polyethyenimine (stPEI)/plasmids/HSA nanoparticles were maded by double emulsion method. They were characterized by dynamic light scattering (DLS), transmission electron microscope and also evaluated by in vitro study on CT 26 cells.
Results:
stPEI was synthesized by an N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride (EDC)-N-hydroxysuccinimide (NHS) reaction, and we found that the degree of substitution was ~1.0 when the ratio of PEI to stearic acid was 1:7 in the reaction. Then, two sgRNA sequences were selected and evaluated for their ability to knock out PD-L1 by decreasing its expression by about 20%. Based on the trend of particle size/zeta potential values as a function of ratio, F25P1 containing 25 μg of plasmid/stPEI/HSA NPs noncovalently bound to 1 μg plasmids via charge-charge interactions was found to be optimal. Its particle size was about 202.7±4.5 nm, and zeta potential was 12.60±0.15 mV. In an in vitro study, these NPs showed little cytotoxicity but high cellular uptake. Moreover, they revealed the potential for transfection and PD-L1 knockout in an in vitro cell model. Furthermore, F25P1S0.5 containing 25 μg of plasmid/stPEI/HSA NPs noncovalently bound to 1 μg of plasmids and 0.5 μg siRNA was prepared to simultaneously deliver plasmids and siRNA. An in vitro study demonstrated that the siRNA did not interfere with the transfection of plasmids and showed a high-transfection efficiency with a synergistic effect on inhibition of PD-L1 expression by 21.95%.
Conclusion:
The plasmids/stPEI/HSA NPs could be a promising tool for gene delivery and improved immunotherapy.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP25952538	N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride		25952-53-8	Price
LS74633	Polyethylenimine hydrochloride			Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: